Monday, 5 April 2021

MCQ-220

 


Answer: c) Entacapone.

Entacapone is a selective and reversible COMT inhibitor which inhibits metabolism of Levodopa thus increases plasma levels of Levodopa which is needed for more constant dopaminergic stimulation that is required to reduce the signs and symptoms presented in Parkinson’s disease.


No comments:

Post a Comment